Pharmacogenomics

Study Shows Substantial Cost Can be Avoided When Incorporating Pharmacogenomics in Programs of All-inclusive Care for the Elderly

Adoption of pharmacogenomic (PGx) testing into clinical practice has been slow. One barrier for implementation is the cost associated with testing, which discourages patients, clinicians, and payers. Demonstrating the potential economic impact from PGx testing [...]

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4